News
Language
Live Cam
Contact
Imprint
Ulm
English
en
Deutsch
de
Français
fr
News
Language
Live Cam
Contact
Imprint
English
en
Deutsch
de
Français
fr
EKM WS18 Introduction to Clinical Medicine
GTE Historical development of medicine
Medicine
Button
Robert Koch Institute
Red List
Pub Med
Dolosys
Cardiology
APR
22
Sotatercept as add-on therapy for advanced PAH
By:
Xiulin Köhler
on
APR
22
Nature Reviews Cardiology, Published online: 22 April 2025; doi:10.1038/s41569-025-01161-ySotatercept, an activin-signalling inhibitor, is a promising add-on treatment for patients with advanced pulmonary arterial hypertension and a high risk of death, according to data from the ZENITH trial.
Read more >>
APR
16
Pulsed field ablation non-inferior to cryoablation for paroxysmal AF
By:
Irene Fernández-Ruiz
on
APR
16
Nature Reviews Cardiology, Published online: 16 April 2025; doi:10.1038/s41569-025-01159-6In patients with symptomatic paroxysmal atrial fibrillation, pulsed field ablation is non-inferior to cryoballoon ablation for preventing the recurrence of atrial tachyarrhythmia, according to findings from the SINGLE SHOT CHAMPION trial.
Read more >>
APR
14
Expanding cardiovascular indications for semaglutide: results from the SOUL and STRIDE trials
By:
Karina Huynh
on
APR
14
Nature Reviews Cardiology, Published online: 14 April 2025; doi:10.1038/s41569-025-01158-7Two clinical trials presented at the ACC.25 describe the expanding indications for the glucagon-like peptide 1 receptor agonist semaglutide in patients with type 2 diabetes mellitus.
Read more >>
APR
14
Post-translational acylation of proteins in cardiac hypertrophy
By:
Ying-Qi Liu
on
APR
14
Nature Reviews Cardiology, Published online: 14 April 2025; doi:10.1038/s41569-025-01150-1In this Review, Liu, Yang and He explore the diverse mechanisms by which various post-translational protein acylations, and the dynamic interactions between them, contribute to cardiac hypertrophy. The authors also discuss the therapeutic potential of targeting acylations to modulate their effects on chromatin architecture, enzyme activity and metabolic pathways.
Read more >>
APR
10
No effect of cerebral embolic protection devices on stroke risk after TAVI
By:
Irene Fernández-Ruiz
on
APR
10
Nature Reviews Cardiology, Published online: 10 April 2025; doi:10.1038/s41569-025-01156-9Findings from the BHF PROTECT-TAVI trial indicate that the routine use of cerebral embolic protection devices during transcatheter aortic valve implantation does not decrease the incidence of stroke within 72 h after the intervention.
Read more >>
APR
10
Development of a miniature, bioresorbable, light-activated pacemaker
By:
Gregory B. Lim
on
APR
10
Nature Reviews Cardiology, Published online: 10 April 2025; doi:10.1038/s41569-025-01157-8Researchers have engineered a millimetre-scale, bioresorbable, optoelectronic system that can be minimally invasively implanted into the heart and wirelessly controlled by a light source on the surface of the skin to provide temporary cardiac pacing.
Read more >>
APR
10
Apolipoprotein B100 revisited
By:
Mia S. Manojlovic
on
APR
10
Nature Reviews Cardiology, Published online: 10 April 2025; doi:10.1038/s41569-025-01155-wMia Manojlovic and Melaku Taye Amogne highlight the 1986 study that unravelled the primary structure of apolipoprotein B100 and laid a foundation for subsequent studies on the role of this apolipoprotein.
Read more >>
APR
08
Primordial prevention of cardiovascular disease
By:
Hooi Min Lim
on
APR
08
Nature Reviews Cardiology, Published online: 08 April 2025; doi:10.1038/s41569-025-01153-yHooi Min Lim describes how the Bogalusa Heart Study emphasized the importance of primordial prevention of cardiovascular disease and profoundly influenced subsequent cardiovascular research on children and adolescents.
Read more >>
Weitere Beiträge
Clinical Oncology
APR
23
Sacituzumab tirumotecan improves OS in mTNBC
By:
David Killock
on
APR
23
Nature Reviews Clinical Oncology, Published online: 23 April 2025; doi:10.1038/s41571-025-01022-0Sacituzumab tirumotecan improves OS in mTNBC
Read more >>
APR
11
FDA approvals in 2024: new options for patients across cancer types and therapeutic classes
By:
Sundeep Agrawal
on
APR
11
Nature Reviews Clinical Oncology, Published online: 11 April 2025; doi:10.1038/s41571-025-01018-wIn 2024, the US FDA approved several new agents for the treatment of patients with cancer, including small-molecule inhibitors, immune-checkpoint inhibitors, bispecific antibodies, antibody–drug conjugates and cell and gene therapy products. Areas of regulatory focus included the accelerated approval programme and diligent completion of post-marketing trials, convening of Oncologic Drugs Advisory Committee meetings to ensure transparent discussions of complex regulatory issues, and continuation of robust, meaningful engagement with the oncology community to foster efficient drug development.
Read more >>
APR
07
HER2 testing: evolution and update for a companion diagnostic assay
By:
Charles J. Robbins
on
APR
07
Nature Reviews Clinical Oncology, Published online: 07 April 2025; doi:10.1038/s41571-025-01016-yThe development of companion diagnostic assays enabling the detection and quantification of HER2 expression and ERBB2 amplifications has provided an important early example that has informed the development of many companion diagnostics for the identification of other drug targets. However, the introduction of trastuzumab deruxtecan and, potentially, other novel antibody–drug conjugates has created the need for assays that are much more sensitive. In this Review, the authors describe the historical development of HER2 companion diagnostic assays in breast and other HER2-positive cancers and highlight the possible, future, more sensitive methods of HER2 detection and quantification that might provide the next generation of companion diagnostics.
Read more >>
APR
07
Opportunities and challenges for MRD assessment in the clinical management of multiple myeloma
By:
Bruno Paiva
on
APR
07
Nature Reviews Clinical Oncology, Published online: 07 April 2025; doi:10.1038/s41571-025-01017-xMultiple myeloma is a malignancy at the forefront of measurable residual disease (MRD) assessment. In this Review, the authors describe the evolution of MRD analysis in multiple myeloma from technical and clinical standpoints, and discuss opportunities and challenges for MRD-guided management of this disease.
Read more >>
APR
03
Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers
By:
Margherita Ambrosini
on
APR
03
Nature Reviews Clinical Oncology, Published online: 03 April 2025; doi:10.1038/s41571-025-01015-zTumours with deficient DNA mismatch repair (dMMR) leading to a microsatellite instability-high (MSI-H) phenotype are characterized by a high burden of immunogenic mutations and, thus, an immunological ‘hot’ microenvironment that is associated with high sensitivity to immune-checkpoint inhibitors. In this Review, the authors discuss the epidemiology, biology, pathogenesis, clinical diagnosis and treatment of MSI-H/dMMR tumours, highlighting idiosyncrasies associated with specific pathogenetic alterations and tumour histologies.
Read more >>
MAR
24
Surrogate end points in oncology: the speed–uncertainty trade-off from the patients’ perspective
By:
Vinay Prasad
on
MAR
24
Nature Reviews Clinical Oncology, Published online: 24 March 2025; doi:10.1038/s41571-025-01007-zSurrogate end points in drug regulation are thought to reduce the time required to bring new drugs to market; however, only a few of the drugs approved on the basis of these outcomes have subsequently demonstrated robust improvements in overall survival (OS). If the FDA and other regulators were to shift their priority to patient-centred outcomes, such as OS, I argue that such a shift would probably lead to fewer, but also a higher standard of drugs entering the market, potentially with faster approval decisions because novel therapies would initially be tested in later lines and in patients with a worse prognosis.
Read more >>
MAR
19
Stereotactic radiosurgery for patients with brain metastases: current principles, expanding indications and opportunities for multidisciplinary care
By:
Alireza Mansouri
on
MAR
19
Nature Reviews Clinical Oncology, Published online: 19 March 2025; doi:10.1038/s41571-025-01013-1Stereotactic radiosurgery (SRS) has been established as a key therapeutic modality for the management of brain metastases. In this Review, an international group of experts discuss the expanding opportunities for SRS, including application for larger brain metastases and cumulative intracranial tumour volumes, fractionated delivery, neoadjuvant use and combinatorial approaches with modern systemic therapy, as well as associated challenges and remaining questions.
Read more >>
MAR
14
Emerging importance of HER3 in tumorigenesis and cancer therapy
By:
Joan T. Garrett
on
MAR
14
Nature Reviews Clinical Oncology, Published online: 14 March 2025; doi:10.1038/s41571-025-01008-yHER3 is emerging as a promising therapeutic target that is often overexpressed or genetically altered across diverse solid tumour types. This Review describes the landscape of HER3 alterations in cancer and their prognostic implications, the roles of HER3 in oncogenesis and resistance to targeted therapies, and the ongoing clinical development of agents targeting HER3.
Read more >>
Weitere Beiträge
Endocrinology
APR
22
A modified liver enzyme with enhanced stability helps to control glycaemia
By:
Senegal Carty
on
APR
22
Nature Reviews Endocrinology, Published online: 22 April 2025; doi:10.1038/s41574-025-01119-7A modified liver enzyme with enhanced stability helps to control glycaemia
Read more >>
APR
22
Neuro–immuno–endocrinology of the skin: how environment regulates body homeostasis
By:
Radomir M. Slominski
on
APR
22
Nature Reviews Endocrinology, Published online: 22 April 2025; doi:10.1038/s41574-025-01107-xThe skin is not only a physical barrier between the body and the environment but also contains neural, immune and endocrine factors acting together to respond to external stimuli. This Review discusses the role of the skin as a neuro–immuno–endocrine organ and its influence on whole-body homeostasis and allostasis.
Read more >>
APR
17
Insulin resistance in type 2 diabetes mellitus
By:
Domenico Accili
on
APR
17
Nature Reviews Endocrinology, Published online: 17 April 2025; doi:10.1038/s41574-025-01114-yThis Review covers the mechanistic relationship between hyperinsulinaemia and insulin resistance in type 2 diabetes mellitus. The article discusses how changes in insulin signalling affect metabolism and disease progression in various organs and cell types.
Read more >>
APR
17
Potential downsides of calorie restriction
By:
Anyongqi Wang
on
APR
17
Nature Reviews Endocrinology, Published online: 17 April 2025; doi:10.1038/s41574-025-01111-1Calorie restriction extends lifespan in many animal models; however, the effects in humans and the mechanisms of action are not clear. This Review summarizes evidence regarding potential adverse effects of calorie restriction and highlights the complexity of extrapolating findings from animal studies to humans.
Read more >>
APR
14
Older people with type 1 diabetes mellitus: a call for a new management approach
By:
Giuseppe Maltese
on
APR
14
Nature Reviews Endocrinology, Published online: 14 April 2025; doi:10.1038/s41574-025-01118-8The growing population of older adults with type 1 diabetes mellitus presents unique challenges, including frailty, comorbidities and polypharmacy. A holistic multidisciplinary approach is crucial to address this population’s complex needs, improve care delivery, and ensure their independence and quality of life amid the realities of ageing with this lifelong condition.
Read more >>
APR
11
Author Correction: Adrenocortical stem cells in health and disease
By:
Yulan Chu
on
APR
11
Nature Reviews Endocrinology, Published online: 11 April 2025; doi:10.1038/s41574-025-01108-wAuthor Correction: Adrenocortical stem cells in health and disease
Read more >>
APR
09
mTORC1 is the central regulator in pancreatic β-cells
By:
Pei Xu
on
APR
09
Nature Reviews Endocrinology, Published online: 09 April 2025; doi:10.1038/s41574-025-01116-wmTORC1 is the central regulator in pancreatic β-cells
Read more >>
APR
07
Highlights from SfE BES 2025
By:
Olivia Tysoe
on
APR
07
Nature Reviews Endocrinology, Published online: 07 April 2025; doi:10.1038/s41574-025-01112-0Highlights from SfE BES 2025
Read more >>
Weitere Beiträge
GI and Hepatology
APR
22
Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response
By:
Virginia Solitano
on
APR
22
Nature Reviews Gastroenterology & Hepatology, Published online: 22 April 2025; doi:10.1038/s41575-025-01063-xInflammatory bowel disease (IBD) is an immune-mediated disease with substantial burden worldwide. In this Consensus Statement, a global multidisciplinary group of experts identify key priorities and recommendations to raise awareness and advance IBD care and research.
Read more >>
APR
14
CAR T cell therapies in gastrointestinal cancers: current clinical trials and strategies to overcome challenges
By:
Hinrich Abken
on
APR
14
Nature Reviews Gastroenterology & Hepatology, Published online: 14 April 2025; doi:10.1038/s41575-025-01062-yIn this Review, Abken provides an overview of clinical trials exploring the use of chimeric antigen receptor (CAR) T cells in gastrointestinal cancers, including colorectal, pancreatic, gastric and oesophageal cancers. Limitations and strategies to overcome challenges are discussed.
Read more >>
APR
10
Diet-driven microbiome restoration associated with cardiometabolic benefits
By:
Jordan Hindson
on
APR
10
Nature Reviews Gastroenterology & Hepatology, Published online: 10 April 2025; doi:10.1038/s41575-025-01067-7Diet-driven microbiome restoration associated with cardiometabolic benefits
Read more >>
APR
08
Metabolic diseases in the East Asian populations
By:
Zhonghan Sun
on
APR
08
Nature Reviews Gastroenterology & Hepatology, Published online: 08 April 2025; doi:10.1038/s41575-025-01058-8The East Asian population is experiencing a continuous rise in metabolic disease burden. This Review provides a detailed account of epidemiological data and discusses risk factors and therapeutic approaches, offering valuable insights into region-specific drivers and therapeutic strategies.
Read more >>
APR
04
A sensory neuron–gastric cancer circuit
By:
Eleni Kotsiliti
on
APR
04
Nature Reviews Gastroenterology & Hepatology, Published online: 04 April 2025; doi:10.1038/s41575-025-01066-8A sensory neuron–gastric cancer circuit
Read more >>
APR
04
Behavioural interventions increase uptake of CRC screening
By:
Katrina Ray
on
APR
04
Nature Reviews Gastroenterology & Hepatology, Published online: 04 April 2025; doi:10.1038/s41575-025-01064-wBehavioural interventions increase uptake of CRC screening
Read more >>
APR
04
International collaborative research to improve gallbladder cancer prevention
By:
Dominique Scherer
on
APR
04
Nature Reviews Gastroenterology & Hepatology, Published online: 04 April 2025; doi:10.1038/s41575-025-01061-zThe European–Latin American Research Consortium towards Eradication of Preventable Gallbladder Cancer (EULAT Eradicate GBC) is identifying geographical, environmental, lifestyle, genetic and molecular risk factors for gallbladder cancer. Collaborative research is essential to improve prevention of this aggressive tumour, especially in high-incidence, low-income and middle-income regions.
Read more >>
MAR
24
Incorporating genetic variations in alcohol-associated liver disease trials for East Asian populations
By:
Bossng Kang
on
MAR
24
Nature Reviews Gastroenterology & Hepatology, Published online: 24 March 2025; doi:10.1038/s41575-025-01060-0Incorporating genetic variations in alcohol-associated liver disease trials for East Asian populations
Read more >>
Weitere Beiträge
Nephrology
APR
24
Dialysis and cognitive impairment
By:
Chris W. McIntyre
on
APR
24
Nature Reviews Nephrology, Published online: 24 April 2025; doi:10.1038/s41581-025-00960-3Treatment with dialysis in people with kidney failure has been implicated in accelerated cognitive impairment. Here, the authors consider how dialysis treatment — haemodialysis and peritoneal dialysis — can promote cerebral injury and might exacerbate chronic kidney disease-associated brain alterations and cognitive decline.
Read more >>
APR
23
Magnetic resonance imaging of renal oxygenation
By:
Thoralf Niendorf
on
APR
23
Nature Reviews Nephrology, Published online: 23 April 2025; doi:10.1038/s41581-025-00956-zMRI is a powerful technology for assessment of renal oxygenation. This Review highlights important considerations for the physiological interpretation of renal oxygenation changes measured by MR oximetry and discusses use of this technology in research as well as potential clinical applications.
Read more >>
APR
22
GalNAc-T14-associated defects in B cell homing in IgA nephropathy
By:
Susan J. Allison
on
APR
22
Nature Reviews Nephrology, Published online: 22 April 2025; doi:10.1038/s41581-025-00964-zGalNAc-T14-associated defects in B cell homing in IgA nephropathy
Read more >>
APR
22
Innate immune cells in acute and chronic kidney disease
By:
Xiao-ming Meng
on
APR
22
Nature Reviews Nephrology, Published online: 22 April 2025; doi:10.1038/s41581-025-00958-xHere, the authors describe the mechanisms by which innate immune cells contribute to acute kidney injury, the transition from acute kidney injury to chronic kidney disease, and the progression of chronic kidney disease. They also discuss potential therapeutic strategies that target the innate immune system.
Read more >>
APR
07
From big data to smart decisions: artificial intelligence in kidney risk assessment
By:
Devon A. Barnes
on
APR
07
Nature Reviews Nephrology, Published online: 07 April 2025; doi:10.1038/s41581-025-00962-1Artificial intelligence approaches that link patient data with chemical-induced kidney injury patterns are revolutionizing nephrotoxicity risk assessment. Substantial progress has been made in the development of integrated approaches that leverage big data, molecular profiles and toxicological understanding to identify at-risk patients, provide insights into molecular mechanisms and advance predictive nephrology.
Read more >>
APR
03
Assessing the effect of social and environmental burdens on kidney disease
By:
Mukoso N. Ozieh
on
APR
03
Nature Reviews Nephrology, Published online: 03 April 2025; doi:10.1038/s41581-025-00955-0Social and environmental exposures are strong drivers of health inequity and adverse health outcomes. However, data from studies that examine the longitudinal effect of social and environmental exposure burdens on kidney disease outcomes are limited. The environmental justice index–social environmental ranking, although imperfect, provides an important tool to address this gap in knowledge.
Read more >>
APR
02
From fat to filter: the effect of adipose tissue-derived signals on kidney function
By:
Nermin Ahmed
on
APR
02
Nature Reviews Nephrology, Published online: 02 April 2025; doi:10.1038/s41581-025-00950-5Obesity exerts both direct and indirect effects on the kidney. This Review describes the mechanisms by which adipose-derived signals, including neural and hormonal signals, compromise kidney filtration capacity and discusses current and emerging renoprotective therapies that may provide benefit in the context of obesity and metabolic disease.
Read more >>
APR
01
Association of
LILRB3
variants with kidney transplant failure in African Americans
By:
Susan J. Allison
on
APR
01
Nature Reviews Nephrology, Published online: 01 April 2025; doi:10.1038/s41581-025-00959-wAssociation of LILRB3 variants with kidney transplant failure in African Americans
Read more >>
Weitere Beiträge
Neurology
APR
14
Women’s neurology: a growing subspeciality to tackle sex and gender disparities
By:
Lisa Kiani
on
APR
14
Nature Reviews Neurology, Published online: 14 April 2025; doi:10.1038/s41582-025-01088-5We spoke with neurologist Esther Bui from Canada about her work to improve neurological health for women.
Read more >>
APR
14
Alzheimer disease seen through the lens of sex and gender
By:
Laura Castro-Aldrete
on
APR
14
Nature Reviews Neurology, Published online: 14 April 2025; doi:10.1038/s41582-025-01071-0Sex and gender influence the entire healthcare ecosystem of Alzheimer disease (AD). In this Review, Castro-Aldrete et al. present a holistic view of sex and gender in AD, and discuss how these factors affect research and policy efforts to improve AD prevention, diagnosis and treatment.
Read more >>
APR
10
Multi-ancestry GWAS identifies 16 novel Alzheimer disease risk loci
By:
Lisa Kiani
on
APR
10
Nature Reviews Neurology, Published online: 10 April 2025; doi:10.1038/s41582-025-01086-7Multi-ancestry GWAS identifies 16 novel Alzheimer disease risk loci
Read more >>
APR
10
Microglia underlie amyloid-β clearance in immunized people with Alzheimer disease
By:
Lisa Kiani
on
APR
10
Nature Reviews Neurology, Published online: 10 April 2025; doi:10.1038/s41582-025-01084-9Microglia underlie amyloid-β clearance in immunized people with Alzheimer disease
Read more >>
APR
10
Pharmacological rehabilitation for stroke
By:
Lisa Kiani
on
APR
10
Nature Reviews Neurology, Published online: 10 April 2025; doi:10.1038/s41582-025-01087-6Pharmacological rehabilitation for stroke
Read more >>
APR
10
Neurofilament light chain induces neuroinflammation
By:
Lisa Kiani
on
APR
10
Nature Reviews Neurology, Published online: 10 April 2025; doi:10.1038/s41582-025-01085-8Neurofilament light chain induces neuroinflammation
Read more >>
APR
10
Walking the Talk for Dementia — an experience to break down barriers
By:
Ian Fyfe
on
APR
10
Nature Reviews Neurology, Published online: 10 April 2025; doi:10.1038/s41582-025-01082-xWalking the Talk for Dementia is no ordinary conference, but an experience that is designed to bring together people with diverse perspectives on dementia, including people with lived experience, and to foster new ways of thinking and collaborating. We asked founder Fernando Aguzzoli-Peres to tell us more about his unique initiative.
Read more >>
APR
04
Epigenetic reprogramming of glioblastoma to overcome chemotherapy resistance
By:
Heather Wood
on
APR
04
Nature Reviews Neurology, Published online: 04 April 2025; doi:10.1038/s41582-025-01083-wResearchers have developed a CRISPR–Cas9-based epigenetic editing approach that sensitizes glioblastoma cells to standard chemotherapy drugs and could improve the treatment of tumours that have developed resistance to these drugs.
Read more >>
Weitere Beiträge
Rheumatology
APR
23
Glycosylation switch in synovial fibroblasts promotes ECM degradation
By:
Holly Webster
on
APR
23
Nature Reviews Rheumatology, Published online: 23 April 2025; doi:10.1038/s41584-025-01258-1Activation of N-acetylgalactosaminyltransferases in synovial fibroblasts promotes the degradation of the extracellular matrix in arthritis.
Read more >>
APR
23
Factors beyond urate levels for managing gout flares
By:
Hang Korng Ea
on
APR
23
Nature Reviews Rheumatology, Published online: 23 April 2025; doi:10.1038/s41584-025-01255-4Urate crystals alone are required but not sufficient to trigger gout flares; they can also be modulated by environmental, metabolic, genetic and epigenetic factors. Avoiding large variation in urate levels, maintaining prophylaxis until crystal clearance and initiating low-dose urate-lowering therapy are efficient strategies for disease management.
Read more >>
APR
23
Understanding the causes of treatment failure is crucial for the management of axial spondyloarthritis
By:
Denis Poddubnyy
on
APR
23
Nature Reviews Rheumatology, Published online: 23 April 2025; doi:10.1038/s41584-025-01254-5Although numerous therapies are available for axial spondyloarthritis, more than half of patients do not achieve remission or respond to treatment. Understanding the reasons for non-response in axial spondyloarthritis is essential for effective management of this disease.
Read more >>
APR
22
Targeting osteoarthritis where it hurts: the osteochondral junction
By:
Anne-Marie Malfait
on
APR
22
Nature Reviews Rheumatology, Published online: 22 April 2025; doi:10.1038/s41584-025-01257-2In joints with osteoarthritis, angiogenesis and neuronal growth occur at the osteochondral junction, a process that can contribute to structural joint damage and pain. Targeting this neurovascularization process represents a possible strategy for the development of disease-modifying drugs for osteoarthritis.
Read more >>
APR
17
Current challenges in understanding the epidemiology of calcium pyrophosphate crystal deposition
By:
Charlotte Jauffret
on
APR
17
Nature Reviews Rheumatology, Published online: 17 April 2025; doi:10.1038/s41584-025-01256-3Calcium pyrophosphate deposition (CPPD) disease is secondary to the pathological accumulation of calcium pyrophosphate (CPP) crystals inside joints and involves acute or chronic inflammatory arthritis. Epidemiological research on CPPD has been slow despite the suspected high prevalence of this condition. Here we highlight key challenges in CPPD imaging, diagnosis and nomenclature that need to be addressed for epidemiological research to progress at a faster pace.
Read more >>
APR
16
Fumarate drives interferon release in systemic sclerosis monocytes
By:
Sarah Onuora
on
APR
16
Nature Reviews Rheumatology, Published online: 16 April 2025; doi:10.1038/s41584-025-01261-6Altered metabolism of the tricarboxylic acid cycle metabolite fumarate drives activation of interferon release in systemic sclerosis monocytes, suggesting a potential therapeutic approach.
Read more >>
APR
15
Upadacitinib effective for GCA in phase III trial
By:
Sarah Onuora
on
APR
15
Nature Reviews Rheumatology, Published online: 15 April 2025; doi:10.1038/s41584-025-01260-7In the phase III SELECT-GCA trial, upadacitinib at a dose of 15 mg daily was superior to placebo with respect to achievement of sustained remission of giant cell arteritis at 52 weeks.
Read more >>
APR
11
Lipid nanoparticles with PDL1-encoding mRNA spread tolerance
By:
Maria Papatriantafyllou
on
APR
11
Nature Reviews Rheumatology, Published online: 11 April 2025; doi:10.1038/s41584-025-01251-8Lipid nanoparticle carriers of immunosuppressive mRNA shape tolerogenic antigen-presenting cells that inhibit arthritis progression in mice.
Read more >>
Weitere Beiträge
Urology
APR
15
Circulating tumour DNA and circulating tumour cells in bladder cancer — from discovery to clinical implementation
By:
Sia V. Lindskrog
on
APR
15
Nature Reviews Urology, Published online: 15 April 2025; doi:10.1038/s41585-025-01023-9In this Review, the authors provide an overview of circulating tumour DNA and circulating tumour cells as potential biomarkers to provide therapeutic guidance and optimize disease surveillance in bladder cancer. Challenges associated with these biomarkers and future perspectives for clinical implementation are also discussed.
Read more >>
APR
14
Targeting TGCT
By:
Louise Lloyd
on
APR
14
Nature Reviews Urology, Published online: 14 April 2025; doi:10.1038/s41585-025-01040-8Targeting TGCT
Read more >>
APR
14
Madrid plays host to a celebration of urology
By:
Annette Fenner
on
APR
14
Nature Reviews Urology, Published online: 14 April 2025; doi:10.1038/s41585-025-01036-4Madrid plays host to a celebration of urology
Read more >>
APR
14
Stepping up to prevent bacterial vaginosis recurrence
By:
Louise Lloyd
on
APR
14
Nature Reviews Urology, Published online: 14 April 2025; doi:10.1038/s41585-025-01039-1Stepping up to prevent bacterial vaginosis recurrence
Read more >>
APR
14
Sexual transfer of bacteria for forensic use
By:
Annette Fenner
on
APR
14
Nature Reviews Urology, Published online: 14 April 2025; doi:10.1038/s41585-025-01037-3Sexual transfer of bacteria for forensic use
Read more >>
APR
14
Evolving language reflects evolving understanding: updated terms for anatomical description in i/VSC/DSD
By:
Jax Whitehead
on
APR
14
Nature Reviews Urology, Published online: 14 April 2025; doi:10.1038/s41585-025-01035-5Medical terminology requires periodic updates based on the input of affected communities and/or to reflect advances in scientific understanding. An update to terminology to replace the terms ‘ambiguous’ and ‘atypical’ as descriptors of external genital anatomy in the intersex, variations of sex characteristics and differences of sex development (i/VSC/DSD) field could be an important step forwards in the field.
Read more >>
APR
09
Microultrasonography-guided prostate cancer biopsy
By:
Maria Chiara Masone
on
APR
09
Nature Reviews Urology, Published online: 09 April 2025; doi:10.1038/s41585-025-01033-7Microultrasonography-guided prostate cancer biopsy
Read more >>
APR
09
Neural control of male sexual behaviours
By:
Maria Chiara Masone
on
APR
09
Nature Reviews Urology, Published online: 09 April 2025; doi:10.1038/s41585-025-01034-6Neural control of male sexual behaviours
Read more >>
Weitere Beiträge
Share
Tweet
Share
Mail
English version of this site is mostly translated automatically using "google translate". In case of language difficulties please do not hesitate to contact me.
Share by: